Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway | Zendy

Harvinder Chahal | Zendy; Giampaolo Trivellin | Zendy; Chrysanthia A. Leontiou | Zendy; Neda Alband | Zendy; Robert C. Fowkes | Zendy; Asil Tahir | Zendy; Susana Igreja | Zendy; J. Paul Chapple | Zendy; Susan J. Jordan | Zendy; Amelie Lupp | Zendy; Stefan Schulz | Zendy; Olaf Ansorge | Zendy; Niki Karavitaki | Zendy; Eivind Carlsen | Zendy; John Wass | Zendy; Ashley Grossman | Zendy; Márta Korbonits | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway

Author(s) -

Harvinder Chahal,

Giampaolo Trivellin,

Chrysanthia A. Leontiou,

Neda Alband,

Robert C. Fowkes,

Asil Tahir,

Susana Igreja,

J. Paul Chapple,

Susan J. Jordan,

Amelie Lupp,

Stefan Schulz,

Olaf Ansorge,

Niki Karavitaki,

Eivind Carlsen,

John Wass,

Ashley Grossman,

Márta Korbonits

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-1111

Subject(s) - lanreotide , somatostatin , acromegaly , endocrinology , medicine , somatostatin receptor , octreotide , somatostatin receptor 2 , gene knockdown , apoptosis , biology , microbiology and biotechnology , cancer research , hormone , growth hormone , biochemistry

Somatotroph adenomas harboring aryl hydrocarbon receptor interacting protein (AIP) mutations respond less well to somatostatin analogs, suggesting that the effects of somatostatin analogs may be mediated by AIP.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research